

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.54753280 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.54753280 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.45386259 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.45386259 |
| 5 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.91363991 |
| 6 | synaptic vesicle maturation (GO:0016188) | 5.80800332 |
| 7 | glutamate secretion (GO:0014047) | 5.77177736 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 5.66306129 |
| 9 | alpha-linolenic acid metabolic process (GO:0036109) | 5.60521274 |
| 10 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.59748625 |
| 11 | synaptic vesicle exocytosis (GO:0016079) | 5.42456406 |
| 12 | glyoxylate metabolic process (GO:0046487) | 5.26667289 |
| 13 | pyrimidine nucleobase catabolic process (GO:0006208) | 5.26201963 |
| 14 | kynurenine metabolic process (GO:0070189) | 5.24551170 |
| 15 | cerebellar granule cell differentiation (GO:0021707) | 5.17564317 |
| 16 | bile acid biosynthetic process (GO:0006699) | 5.10033846 |
| 17 | cellular ketone body metabolic process (GO:0046950) | 5.06298422 |
| 18 | high-density lipoprotein particle remodeling (GO:0034375) | 5.03546862 |
| 19 | sulfur amino acid catabolic process (GO:0000098) | 4.95140847 |
| 20 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.95074553 |
| 21 | indole-containing compound catabolic process (GO:0042436) | 4.90988716 |
| 22 | indolalkylamine catabolic process (GO:0046218) | 4.90988716 |
| 23 | tryptophan catabolic process (GO:0006569) | 4.90988716 |
| 24 | negative regulation of fibrinolysis (GO:0051918) | 4.88131518 |
| 25 | urea cycle (GO:0000050) | 4.82911920 |
| 26 | urea metabolic process (GO:0019627) | 4.82911920 |
| 27 | cysteine metabolic process (GO:0006534) | 4.82501664 |
| 28 | serine family amino acid catabolic process (GO:0009071) | 4.79187410 |
| 29 | lysine catabolic process (GO:0006554) | 4.76970846 |
| 30 | lysine metabolic process (GO:0006553) | 4.76970846 |
| 31 | cellular potassium ion homeostasis (GO:0030007) | 4.75247755 |
| 32 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.67892586 |
| 33 | positive regulation of synapse maturation (GO:0090129) | 4.66240572 |
| 34 | tryptophan metabolic process (GO:0006568) | 4.59031090 |
| 35 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.57818134 |
| 36 | regulation of fibrinolysis (GO:0051917) | 4.53618756 |
| 37 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.51506257 |
| 38 | regulation of triglyceride catabolic process (GO:0010896) | 4.51066060 |
| 39 | locomotory exploration behavior (GO:0035641) | 4.50588458 |
| 40 | amino-acid betaine metabolic process (GO:0006577) | 4.48442099 |
| 41 | neurotransmitter secretion (GO:0007269) | 4.45376889 |
| 42 | nitrogen cycle metabolic process (GO:0071941) | 4.44653439 |
| 43 | protein carboxylation (GO:0018214) | 4.43871618 |
| 44 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.43871618 |
| 45 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.43179101 |
| 46 | regulation of cholesterol esterification (GO:0010872) | 4.36863513 |
| 47 | reverse cholesterol transport (GO:0043691) | 4.36836920 |
| 48 | negative regulation of cholesterol transport (GO:0032375) | 4.36085706 |
| 49 | negative regulation of sterol transport (GO:0032372) | 4.36085706 |
| 50 | regulation of protein activation cascade (GO:2000257) | 4.35604610 |
| 51 | bile acid metabolic process (GO:0008206) | 4.34947081 |
| 52 | ketone body metabolic process (GO:1902224) | 4.33659398 |
| 53 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.30128146 |
| 54 | glutamate metabolic process (GO:0006536) | 4.29445701 |
| 55 | nucleobase catabolic process (GO:0046113) | 4.28035843 |
| 56 | dendritic spine morphogenesis (GO:0060997) | 4.25293777 |
| 57 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.21363069 |
| 58 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.19839758 |
| 59 | cell migration in hindbrain (GO:0021535) | 4.19645737 |
| 60 | neuronal ion channel clustering (GO:0045161) | 4.19574090 |
| 61 | protein-lipid complex remodeling (GO:0034368) | 4.19224017 |
| 62 | macromolecular complex remodeling (GO:0034367) | 4.19224017 |
| 63 | plasma lipoprotein particle remodeling (GO:0034369) | 4.19224017 |
| 64 | complement activation, alternative pathway (GO:0006957) | 4.17516466 |
| 65 | alpha-amino acid catabolic process (GO:1901606) | 4.16094528 |
| 66 | acylglycerol homeostasis (GO:0055090) | 4.16016169 |
| 67 | triglyceride homeostasis (GO:0070328) | 4.16016169 |
| 68 | glycine metabolic process (GO:0006544) | 4.13534323 |
| 69 | aromatic amino acid family metabolic process (GO:0009072) | 4.12118824 |
| 70 | ethanol oxidation (GO:0006069) | 4.10693356 |
| 71 | auditory behavior (GO:0031223) | 4.08857228 |
| 72 | phospholipid efflux (GO:0033700) | 4.08094318 |
| 73 | coenzyme catabolic process (GO:0009109) | 4.06025956 |
| 74 | regulation of complement activation (GO:0030449) | 4.03217787 |
| 75 | negative regulation of leukocyte chemotaxis (GO:0002689) | 3.99214459 |
| 76 | cellular amino acid catabolic process (GO:0009063) | 3.95096738 |
| 77 | tyrosine metabolic process (GO:0006570) | 3.87392105 |
| 78 | serine family amino acid metabolic process (GO:0009069) | 3.87144123 |
| 79 | plasma lipoprotein particle clearance (GO:0034381) | 3.84785428 |
| 80 | acetyl-CoA metabolic process (GO:0006084) | 3.80397082 |
| 81 | cellular modified amino acid catabolic process (GO:0042219) | 3.79969452 |
| 82 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.79723963 |
| 83 | aspartate family amino acid catabolic process (GO:0009068) | 3.76661136 |
| 84 | homocysteine metabolic process (GO:0050667) | 3.76105766 |
| 85 | regulation of synaptic vesicle transport (GO:1902803) | 3.73306670 |
| 86 | sodium ion export (GO:0071436) | 3.71990129 |
| 87 | regulation of vesicle fusion (GO:0031338) | 3.69865440 |
| 88 | regulation of cholesterol homeostasis (GO:2000188) | 3.68854581 |
| 89 | cellular glucuronidation (GO:0052695) | 3.68346590 |
| 90 | drug catabolic process (GO:0042737) | 3.68262199 |
| 91 | short-chain fatty acid metabolic process (GO:0046459) | 3.62656915 |
| 92 | positive regulation of neurotransmitter transport (GO:0051590) | 3.62211281 |
| 93 | cholesterol efflux (GO:0033344) | 3.60485003 |
| 94 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.60137221 |
| 95 | positive regulation of lipid catabolic process (GO:0050996) | 3.60121523 |
| 96 | imidazole-containing compound metabolic process (GO:0052803) | 3.59926764 |
| 97 | regulation of synapse structural plasticity (GO:0051823) | 3.56164254 |
| 98 | bile acid and bile salt transport (GO:0015721) | 3.55519304 |
| 99 | postsynaptic membrane organization (GO:0001941) | 3.53694184 |
| 100 | arginine metabolic process (GO:0006525) | 3.53333846 |
| 101 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.52380274 |
| 102 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.51607215 |
| 103 | negative regulation of lipase activity (GO:0060192) | 3.51585770 |
| 104 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.50275220 |
| 105 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.50275220 |
| 106 | serine family amino acid biosynthetic process (GO:0009070) | 3.48677849 |
| 107 | dendritic spine organization (GO:0097061) | 3.47521536 |
| 108 | carboxylic acid catabolic process (GO:0046395) | 3.47396585 |
| 109 | organic acid catabolic process (GO:0016054) | 3.47396585 |
| 110 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.46588855 |
| 111 | benzene-containing compound metabolic process (GO:0042537) | 3.44273841 |
| 112 | 2-oxoglutarate metabolic process (GO:0006103) | 3.44073000 |
| 113 | regulation of synapse maturation (GO:0090128) | 3.43393334 |
| 114 | fatty acid beta-oxidation (GO:0006635) | 3.39487461 |
| 115 | serotonin metabolic process (GO:0042428) | 3.39307083 |
| 116 | cell differentiation in hindbrain (GO:0021533) | 3.39125158 |
| 117 | carnitine metabolic process (GO:0009437) | 3.39094274 |
| 118 | exploration behavior (GO:0035640) | 3.36866994 |
| 119 | fatty acid oxidation (GO:0019395) | 3.36141847 |
| 120 | synaptic vesicle endocytosis (GO:0048488) | 3.35588215 |
| 121 | dicarboxylic acid catabolic process (GO:0043649) | 3.34685315 |
| 122 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.34671228 |
| 123 | neurotransmitter transport (GO:0006836) | 3.34248523 |
| 124 | indolalkylamine metabolic process (GO:0006586) | 3.33244043 |
| 125 | monocarboxylic acid catabolic process (GO:0072329) | 3.32927424 |
| 126 | mechanosensory behavior (GO:0007638) | 3.32508632 |
| 127 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.32466540 |
| 128 | protein localization to synapse (GO:0035418) | 3.32034305 |
| 129 | positive regulation of membrane potential (GO:0045838) | 3.29588513 |
| 130 | lipid oxidation (GO:0034440) | 3.29366130 |
| 131 | synaptic transmission, glutamatergic (GO:0035249) | 3.28563023 |
| 132 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.28366845 |
| 133 | potassium ion homeostasis (GO:0055075) | 3.27249730 |
| 134 | establishment of mitochondrion localization (GO:0051654) | 3.27028952 |
| 135 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.26026323 |
| 136 | response to misfolded protein (GO:0051788) | 3.25583593 |
| 137 | exogenous drug catabolic process (GO:0042738) | 3.24595657 |
| 138 | regulation of cholesterol metabolic process (GO:0090181) | 3.24532567 |
| 139 | fatty acid catabolic process (GO:0009062) | 3.23232592 |
| 140 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.23102352 |
| 141 | glucuronate metabolic process (GO:0019585) | 3.21149438 |
| 142 | uronic acid metabolic process (GO:0006063) | 3.21149438 |
| 143 | flavonoid metabolic process (GO:0009812) | 3.21033362 |
| 144 | heme transport (GO:0015886) | 3.19051250 |
| 145 | neuronal action potential propagation (GO:0019227) | 3.18786956 |
| 146 | low-density lipoprotein particle remodeling (GO:0034374) | 3.18418788 |
| 147 | gamma-aminobutyric acid transport (GO:0015812) | 3.16989443 |
| 148 | primary amino compound metabolic process (GO:1901160) | 3.16694049 |
| 149 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.15071071 |
| 150 | chemosensory behavior (GO:0007635) | 3.14178181 |
| 151 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.13629928 |
| 152 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.13422023 |
| 153 | glycerophospholipid catabolic process (GO:0046475) | 3.09653439 |
| 154 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.08155485 |
| 155 | substrate-independent telencephalic tangential migration (GO:0021826) | 3.07314428 |
| 156 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 3.07314428 |
| 157 | neuron-neuron synaptic transmission (GO:0007270) | 3.06182026 |
| 158 | vocalization behavior (GO:0071625) | 3.05561704 |
| 159 | central nervous system myelination (GO:0022010) | 3.04478805 |
| 160 | axon ensheathment in central nervous system (GO:0032291) | 3.04478805 |
| 161 | regulation of neurotransmitter levels (GO:0001505) | 3.04219864 |
| 162 | response to auditory stimulus (GO:0010996) | 3.03444477 |
| 163 | cellular sodium ion homeostasis (GO:0006883) | 3.01428942 |
| 164 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.99970796 |
| 165 | axonal fasciculation (GO:0007413) | 2.98730738 |
| 166 | protein polyglutamylation (GO:0018095) | 2.98493431 |
| 167 | regulation of neurotransmitter secretion (GO:0046928) | 2.97873622 |
| 168 | mitochondrion transport along microtubule (GO:0047497) | 2.93892203 |
| 169 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.93892203 |
| 170 | regulation of autophagic vacuole assembly (GO:2000785) | 2.92023590 |
| 171 | positive regulation of dendritic spine development (GO:0060999) | 2.92008668 |
| 172 | presynaptic membrane organization (GO:0097090) | 2.91617345 |
| 173 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.89942487 |
| 174 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.89911762 |
| 175 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.89379615 |
| 176 | regulation of postsynaptic membrane potential (GO:0060078) | 2.89255537 |
| 177 | layer formation in cerebral cortex (GO:0021819) | 2.88821116 |
| 178 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.88298930 |
| 179 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.84311327 |
| 180 | regulation of neurotransmitter transport (GO:0051588) | 2.83141792 |
| 181 | transmission of nerve impulse (GO:0019226) | 2.79947588 |
| 182 | neuron cell-cell adhesion (GO:0007158) | 2.79301514 |
| 183 | regulation of synaptic plasticity (GO:0048167) | 2.74248256 |
| 184 | neurofilament cytoskeleton organization (GO:0060052) | 2.74164184 |
| 185 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.73474342 |
| 186 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.73221306 |
| 187 | potassium ion import (GO:0010107) | 2.72128580 |
| 188 | neuron recognition (GO:0008038) | 2.72100547 |
| 189 | glutamate receptor signaling pathway (GO:0007215) | 2.71379706 |
| 190 | adult walking behavior (GO:0007628) | 2.69610285 |
| 191 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.68248422 |
| 192 | neuromuscular process controlling balance (GO:0050885) | 2.67815169 |
| 193 | membrane depolarization during action potential (GO:0086010) | 2.66037337 |
| 194 | neuromuscular process controlling posture (GO:0050884) | 2.64456012 |
| 195 | cell communication by electrical coupling (GO:0010644) | 2.63252090 |
| 196 | calcium ion-dependent exocytosis (GO:0017156) | 2.61712796 |
| 197 | regulation of membrane repolarization (GO:0060306) | 2.60612617 |
| 198 | neuromuscular synaptic transmission (GO:0007274) | 2.60543063 |
| 199 | long-term memory (GO:0007616) | 2.59500591 |
| 200 | detection of calcium ion (GO:0005513) | 2.58092650 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.49207344 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.69414258 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.88343049 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.01925511 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.97902578 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.24007858 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.15750682 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.38496635 |
| 9 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 3.32074695 |
| 10 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.29562393 |
| 11 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.25542573 |
| 12 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.07003728 |
| 13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.97925317 |
| 14 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.93068066 |
| 15 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.93068066 |
| 16 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.88671451 |
| 17 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.73812761 |
| 18 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.64822749 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.64636369 |
| 20 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.63938650 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.58941478 |
| 22 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.52272956 |
| 23 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.44366864 |
| 24 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.40228751 |
| 25 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.39230822 |
| 26 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.36803752 |
| 27 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.33331623 |
| 28 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.30166817 |
| 29 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.24260274 |
| 30 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.23019170 |
| 31 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.10433073 |
| 32 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.08367435 |
| 33 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 2.02428961 |
| 34 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.95807119 |
| 35 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.79690867 |
| 36 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.79191275 |
| 37 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.77973107 |
| 38 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.73182040 |
| 39 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.66472461 |
| 40 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.57935434 |
| 41 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.57759113 |
| 42 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.55992329 |
| 43 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.54115268 |
| 44 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.49974999 |
| 45 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.47390617 |
| 46 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.45720500 |
| 47 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.43220798 |
| 48 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.43127530 |
| 49 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.40701711 |
| 50 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.40279814 |
| 51 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.39190490 |
| 52 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.36112866 |
| 53 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.34693318 |
| 54 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.34179062 |
| 55 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.31394278 |
| 56 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.29040722 |
| 57 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.27823143 |
| 58 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.27420421 |
| 59 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.27337953 |
| 60 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.26702898 |
| 61 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.16773939 |
| 62 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.16707666 |
| 63 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.14120915 |
| 64 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.11213560 |
| 65 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.08194489 |
| 66 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.06303310 |
| 67 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.04481008 |
| 68 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.04235170 |
| 69 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.00767863 |
| 70 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.00545946 |
| 71 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.00306260 |
| 72 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.97902984 |
| 73 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.97850835 |
| 74 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.97399265 |
| 75 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.94426923 |
| 76 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.93941721 |
| 77 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.93759697 |
| 78 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.93172084 |
| 79 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.93070779 |
| 80 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.91929955 |
| 81 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.91337423 |
| 82 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.91066157 |
| 83 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.90675043 |
| 84 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.89717589 |
| 85 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.89023656 |
| 86 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.88914988 |
| 87 | AR_19668381_ChIP-Seq_PC3_Human | 0.88364458 |
| 88 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.86559825 |
| 89 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.86391268 |
| 90 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.86148545 |
| 91 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.85487891 |
| 92 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.85215815 |
| 93 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.84284044 |
| 94 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.83694102 |
| 95 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.83124654 |
| 96 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.83074340 |
| 97 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.83000640 |
| 98 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.82517267 |
| 99 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.82168195 |
| 100 | * P68_20966046_ChIP-Seq_HELA_Human | 0.82141221 |
| 101 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.81485932 |
| 102 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.80429437 |
| 103 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.79834711 |
| 104 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.79474250 |
| 105 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.79129160 |
| 106 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.78717832 |
| 107 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.78348211 |
| 108 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.78040367 |
| 109 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.77038228 |
| 110 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.77038228 |
| 111 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.76445278 |
| 112 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.76350017 |
| 113 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.76161904 |
| 114 | AR_25329375_ChIP-Seq_VCAP_Human | 0.75726828 |
| 115 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.75612543 |
| 116 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.75493531 |
| 117 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.74686380 |
| 118 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.74259311 |
| 119 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.73226835 |
| 120 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.73011638 |
| 121 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.72155232 |
| 122 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.70988161 |
| 123 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.70912527 |
| 124 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.70677276 |
| 125 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.70186758 |
| 126 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.69961199 |
| 127 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.69553380 |
| 128 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.69340777 |
| 129 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.69247463 |
| 130 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.68742700 |
| 131 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.68712511 |
| 132 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.68182061 |
| 133 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.68092796 |
| 134 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.67917787 |
| 135 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.67176063 |
| 136 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.66818031 |
| 137 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.66801621 |
| 138 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.66195028 |
| 139 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.65801030 |
| 140 | SOX3_22085726_ChIP-Seq_NPCs_Mouse | 0.65325805 |
| 141 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.64909023 |
| 142 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.64803894 |
| 143 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.64771073 |
| 144 | POU3F1_26484290_ChIP-Seq_ESCss_Mouse | 0.64674861 |
| 145 | * E2F1_20622854_ChIP-Seq_HELA_Human | 0.62748459 |
| 146 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.62530329 |
| 147 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.61504073 |
| 148 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.61482482 |
| 149 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.61269858 |
| 150 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.61226963 |
| 151 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.60383408 |
| 152 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.59383835 |
| 153 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.59098670 |
| 154 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.59072852 |
| 155 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.58733549 |
| 156 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.57631217 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.73216120 |
| 2 | MP0005360_urolithiasis | 6.39398236 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.73469821 |
| 4 | MP0005365_abnormal_bile_salt | 5.57277334 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.86778812 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.45901505 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.50227249 |
| 8 | MP0003252_abnormal_bile_duct | 3.43949179 |
| 9 | MP0009840_abnormal_foam_cell | 3.27963963 |
| 10 | MP0003880_abnormal_central_pattern | 3.21561475 |
| 11 | MP0003123_paternal_imprinting | 3.18777180 |
| 12 | MP0003787_abnormal_imprinting | 2.91607365 |
| 13 | MP0009046_muscle_twitch | 2.83516939 |
| 14 | MP0004742_abnormal_vestibular_system | 2.77148879 |
| 15 | MP0003879_abnormal_hair_cell | 2.72181355 |
| 16 | MP0003122_maternal_imprinting | 2.63248854 |
| 17 | MP0002272_abnormal_nervous_system | 2.63152347 |
| 18 | MP0005083_abnormal_biliary_tract | 2.53440387 |
| 19 | MP0005332_abnormal_amino_acid | 2.51011860 |
| 20 | MP0001984_abnormal_olfaction | 2.40747975 |
| 21 | MP0003195_calcinosis | 2.25247868 |
| 22 | MP0005379_endocrine/exocrine_gland_phen | 2.17183622 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 2.15330118 |
| 24 | MP0001666_abnormal_nutrient_absorption | 2.10415347 |
| 25 | MP0002572_abnormal_emotion/affect_behav | 2.08636892 |
| 26 | MP0001486_abnormal_startle_reflex | 2.08541146 |
| 27 | MP0002118_abnormal_lipid_homeostasis | 2.08436566 |
| 28 | MP0002734_abnormal_mechanical_nocicepti | 2.05438055 |
| 29 | MP0001188_hyperpigmentation | 2.02592948 |
| 30 | MP0000609_abnormal_liver_physiology | 1.91857303 |
| 31 | MP0004019_abnormal_vitamin_homeostasis | 1.87282483 |
| 32 | MP0006292_abnormal_olfactory_placode | 1.86114886 |
| 33 | MP0003329_amyloid_beta_deposits | 1.82537005 |
| 34 | MP0002557_abnormal_social/conspecific_i | 1.81104904 |
| 35 | MP0002735_abnormal_chemical_nociception | 1.80912885 |
| 36 | MP0003121_genomic_imprinting | 1.71511700 |
| 37 | MP0000778_abnormal_nervous_system | 1.70155897 |
| 38 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.68662079 |
| 39 | MP0001968_abnormal_touch/_nociception | 1.68480524 |
| 40 | MP0005319_abnormal_enzyme/_coenzyme | 1.68289252 |
| 41 | MP0003868_abnormal_feces_composition | 1.56488100 |
| 42 | MP0003705_abnormal_hypodermis_morpholog | 1.53743872 |
| 43 | MP0001970_abnormal_pain_threshold | 1.52369870 |
| 44 | MP0000604_amyloidosis | 1.50177474 |
| 45 | MP0001905_abnormal_dopamine_level | 1.49933001 |
| 46 | MP0008569_lethality_at_weaning | 1.49841825 |
| 47 | MP0005646_abnormal_pituitary_gland | 1.44385876 |
| 48 | MP0002067_abnormal_sensory_capabilities | 1.41548519 |
| 49 | MP0002882_abnormal_neuron_morphology | 1.39621863 |
| 50 | MP0004130_abnormal_muscle_cell | 1.39272483 |
| 51 | MP0001501_abnormal_sleep_pattern | 1.38779067 |
| 52 | MP0000566_synostosis | 1.38224182 |
| 53 | MP0000955_abnormal_spinal_cord | 1.38216207 |
| 54 | MP0005451_abnormal_body_composition | 1.35252606 |
| 55 | MP0001485_abnormal_pinna_reflex | 1.31484095 |
| 56 | MP0005386_behavior/neurological_phenoty | 1.29532740 |
| 57 | MP0004924_abnormal_behavior | 1.29532740 |
| 58 | MP0005551_abnormal_eye_electrophysiolog | 1.29114215 |
| 59 | MP0002234_abnormal_pharynx_morphology | 1.26507392 |
| 60 | MP0010234_abnormal_vibrissa_follicle | 1.25487692 |
| 61 | MP0002066_abnormal_motor_capabilities/c | 1.24664347 |
| 62 | MP0001529_abnormal_vocalization | 1.21102576 |
| 63 | MP0001502_abnormal_circadian_rhythm | 1.20791238 |
| 64 | MP0002138_abnormal_hepatobiliary_system | 1.18713680 |
| 65 | MP0002163_abnormal_gland_morphology | 1.16983893 |
| 66 | MP0005647_abnormal_sex_gland | 1.16420000 |
| 67 | MP0003633_abnormal_nervous_system | 1.14662328 |
| 68 | MP0006072_abnormal_retinal_apoptosis | 1.14138256 |
| 69 | MP0002736_abnormal_nociception_after | 1.11392824 |
| 70 | MP0001727_abnormal_embryo_implantation | 1.06923064 |
| 71 | MP0001963_abnormal_hearing_physiology | 1.06647305 |
| 72 | MP0002229_neurodegeneration | 1.05062527 |
| 73 | MP0006036_abnormal_mitochondrial_physio | 1.02382017 |
| 74 | MP0004859_abnormal_synaptic_plasticity | 1.00588272 |
| 75 | MP0009643_abnormal_urine_homeostasis | 1.00457744 |
| 76 | MP0006035_abnormal_mitochondrial_morpho | 0.98815035 |
| 77 | MP0002152_abnormal_brain_morphology | 0.97247368 |
| 78 | MP0005266_abnormal_metabolism | 0.96319107 |
| 79 | MP0003631_nervous_system_phenotype | 0.95723941 |
| 80 | MP0001944_abnormal_pancreas_morphology | 0.94878391 |
| 81 | MP0000026_abnormal_inner_ear | 0.94190484 |
| 82 | MP0010386_abnormal_urinary_bladder | 0.93687969 |
| 83 | MP0008789_abnormal_olfactory_epithelium | 0.92822483 |
| 84 | MP0009379_abnormal_foot_pigmentation | 0.92165363 |
| 85 | MP0003137_abnormal_impulse_conducting | 0.92053216 |
| 86 | MP0002752_abnormal_somatic_nervous | 0.91656389 |
| 87 | MP0000598_abnormal_liver_morphology | 0.91262529 |
| 88 | MP0002078_abnormal_glucose_homeostasis | 0.91173411 |
| 89 | MP0003283_abnormal_digestive_organ | 0.89888264 |
| 90 | MP0002249_abnormal_larynx_morphology | 0.88740050 |
| 91 | MP0002909_abnormal_adrenal_gland | 0.88600748 |
| 92 | MP0003878_abnormal_ear_physiology | 0.88474526 |
| 93 | MP0005377_hearing/vestibular/ear_phenot | 0.88474526 |
| 94 | MP0000383_abnormal_hair_follicle | 0.87729647 |
| 95 | MP0001764_abnormal_homeostasis | 0.87511289 |
| 96 | MP0003635_abnormal_synaptic_transmissio | 0.86317617 |
| 97 | MP0000427_abnormal_hair_cycle | 0.86063160 |
| 98 | MP0002638_abnormal_pupillary_reflex | 0.85752752 |
| 99 | MP0002822_catalepsy | 0.85149208 |
| 100 | MP0003186_abnormal_redox_activity | 0.84453966 |
| 101 | MP0009053_abnormal_anal_canal | 0.83572060 |
| 102 | MP0005535_abnormal_body_temperature | 0.83511744 |
| 103 | MP0010678_abnormal_skin_adnexa | 0.83022152 |
| 104 | MP0008961_abnormal_basal_metabolism | 0.83004248 |
| 105 | MP0001348_abnormal_lacrimal_gland | 0.82760375 |
| 106 | MP0001346_abnormal_lacrimal_gland | 0.82760130 |
| 107 | MP0005623_abnormal_meninges_morphology | 0.82580413 |
| 108 | MP0010030_abnormal_orbit_morphology | 0.82472065 |
| 109 | MP0004270_analgesia | 0.82000204 |
| 110 | MP0003634_abnormal_glial_cell | 0.81765260 |
| 111 | MP0000579_abnormal_nail_morphology | 0.81633030 |
| 112 | MP0001270_distended_abdomen | 0.79862669 |
| 113 | MP0000631_abnormal_neuroendocrine_gland | 0.76961745 |
| 114 | MP0005187_abnormal_penis_morphology | 0.76828051 |
| 115 | MP0002063_abnormal_learning/memory/cond | 0.76420987 |
| 116 | MP0002837_dystrophic_cardiac_calcinosis | 0.76166868 |
| 117 | MP0000462_abnormal_digestive_system | 0.76027255 |
| 118 | MP0004510_myositis | 0.75852646 |
| 119 | MP0003656_abnormal_erythrocyte_physiolo | 0.73972855 |
| 120 | MP0001440_abnormal_grooming_behavior | 0.73754021 |
| 121 | MP0000647_abnormal_sebaceous_gland | 0.73472522 |
| 122 | MP0005448_abnormal_energy_balance | 0.73214048 |
| 123 | MP0003938_abnormal_ear_development | 0.73018804 |
| 124 | MP0009642_abnormal_blood_homeostasis | 0.71652404 |
| 125 | MP0005666_abnormal_adipose_tissue | 0.71468222 |
| 126 | MP0004858_abnormal_nervous_system | 0.70167766 |
| 127 | MP0000920_abnormal_myelination | 0.70041249 |
| 128 | MP0004185_abnormal_adipocyte_glucose | 0.69962031 |
| 129 | MP0003861_abnormal_nervous_system | 0.69766886 |
| 130 | MP0003690_abnormal_glial_cell | 0.69181222 |
| 131 | MP0004885_abnormal_endolymph | 0.69091190 |
| 132 | MP0003011_delayed_dark_adaptation | 0.68846374 |
| 133 | MP0004085_abnormal_heartbeat | 0.68574238 |
| 134 | MP0009672_abnormal_birth_weight | 0.67486033 |
| 135 | MP0002971_abnormal_brown_adipose | 0.66383763 |
| 136 | MP0002653_abnormal_ependyma_morphology | 0.65928258 |
| 137 | MP0005376_homeostasis/metabolism_phenot | 0.64711647 |
| 138 | MP0002796_impaired_skin_barrier | 0.63519844 |
| 139 | MP0009745_abnormal_behavioral_response | 0.63031553 |
| 140 | MP0005248_abnormal_Harderian_gland | 0.62688128 |
| 141 | MP0002876_abnormal_thyroid_physiology | 0.61329849 |
| 142 | MP0005334_abnormal_fat_pad | 0.60977873 |
| 143 | MP0009780_abnormal_chondrocyte_physiolo | 0.60581427 |
| 144 | MP0004043_abnormal_pH_regulation | 0.60425887 |
| 145 | MP0001756_abnormal_urination | 0.60159116 |
| 146 | MP0005423_abnormal_somatic_nervous | 0.60142790 |
| 147 | MP0003953_abnormal_hormone_level | 0.59305582 |
| 148 | MP0008872_abnormal_physiological_respon | 0.59276737 |
| 149 | MP0005636_abnormal_mineral_homeostasis | 0.59042746 |
| 150 | MP0009697_abnormal_copulation | 0.56942317 |
| 151 | MP0008874_decreased_physiological_sensi | 0.56760142 |
| 152 | MP0005499_abnormal_olfactory_system | 0.56541644 |
| 153 | MP0005394_taste/olfaction_phenotype | 0.56541644 |
| 154 | MP0002254_reproductive_system_inflammat | 0.55266405 |
| 155 | MP0002269_muscular_atrophy | 0.55015231 |
| 156 | MP0004142_abnormal_muscle_tone | 0.54123765 |
| 157 | MP0009763_increased_sensitivity_to | 0.53311255 |
| 158 | MP0001661_extended_life_span | 0.51695147 |
| 159 | MP0004133_heterotaxia | 0.50814060 |
| 160 | MP0003221_abnormal_cardiomyocyte_apopto | 0.49742249 |
| 161 | MP0000639_abnormal_adrenal_gland | 0.49388329 |
| 162 | MP0002064_seizures | 0.49310945 |
| 163 | MP0003075_altered_response_to | 0.48776318 |
| 164 | MP0002733_abnormal_thermal_nociception | 0.47680336 |
| 165 | MP0009765_abnormal_xenobiotic_induced | 0.47071187 |
| 166 | MP0002069_abnormal_eating/drinking_beha | 0.46901211 |
| 167 | MP0009764_decreased_sensitivity_to | 0.46564476 |
| 168 | MP0006276_abnormal_autonomic_nervous | 0.46046930 |
| 169 | MP0004811_abnormal_neuron_physiology | 0.43224012 |
| 170 | MP0002184_abnormal_innervation | 0.42969720 |
| 171 | MP0003718_maternal_effect | 0.42847501 |
| 172 | MP0002970_abnormal_white_adipose | 0.42750017 |
| 173 | MP0010368_abnormal_lymphatic_system | 0.41662758 |
| 174 | MP0003119_abnormal_digestive_system | 0.41468903 |
| 175 | MP0005084_abnormal_gallbladder_morpholo | 0.41241016 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 6.39252590 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.23965288 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 5.84345779 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.74514519 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 5.58456833 |
| 6 | Xanthomatosis (HP:0000991) | 5.28874272 |
| 7 | Amblyopia (HP:0000646) | 5.10508710 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 4.85332973 |
| 9 | Hyperglycinemia (HP:0002154) | 4.72232605 |
| 10 | Focal motor seizures (HP:0011153) | 4.66615374 |
| 11 | Prolonged partial thromboplastin time (HP:0003645) | 4.62714420 |
| 12 | Hyperammonemia (HP:0001987) | 4.40352071 |
| 13 | Hyperglycinuria (HP:0003108) | 4.28039813 |
| 14 | Hypolipoproteinemia (HP:0010981) | 4.20349748 |
| 15 | Ketosis (HP:0001946) | 4.17342058 |
| 16 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.10158163 |
| 17 | Abnormality of glycine metabolism (HP:0010895) | 4.10158163 |
| 18 | Complement deficiency (HP:0004431) | 4.08039896 |
| 19 | Double outlet right ventricle (HP:0001719) | 3.90237450 |
| 20 | Congenital malformation of the right heart (HP:0011723) | 3.90237450 |
| 21 | Hypoglycemic coma (HP:0001325) | 3.89673377 |
| 22 | Epidermoid cyst (HP:0200040) | 3.86415264 |
| 23 | Hypoalphalipoproteinemia (HP:0003233) | 3.76658008 |
| 24 | Limb dystonia (HP:0002451) | 3.75152317 |
| 25 | Focal seizures (HP:0007359) | 3.73533241 |
| 26 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.68943012 |
| 27 | Epileptic encephalopathy (HP:0200134) | 3.59790717 |
| 28 | Progressive cerebellar ataxia (HP:0002073) | 3.55890229 |
| 29 | Supranuclear gaze palsy (HP:0000605) | 3.51113869 |
| 30 | Delayed CNS myelination (HP:0002188) | 3.48307679 |
| 31 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.46519520 |
| 32 | Visual hallucinations (HP:0002367) | 3.40505018 |
| 33 | Ketoacidosis (HP:0001993) | 3.39611913 |
| 34 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.38750296 |
| 35 | Febrile seizures (HP:0002373) | 3.36719393 |
| 36 | Autoamputation (HP:0001218) | 3.32984256 |
| 37 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.28708990 |
| 38 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.23023030 |
| 39 | Agitation (HP:0000713) | 3.22925672 |
| 40 | Abnormality of the aortic arch (HP:0012303) | 3.17925860 |
| 41 | Fat malabsorption (HP:0002630) | 3.11711600 |
| 42 | Abnormality of the common coagulation pathway (HP:0010990) | 3.09893346 |
| 43 | Joint hemorrhage (HP:0005261) | 3.08560780 |
| 44 | Abnormality of the lower motor neuron (HP:0002366) | 3.07226377 |
| 45 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.02489255 |
| 46 | Hypochromic microcytic anemia (HP:0004840) | 2.97324745 |
| 47 | Action tremor (HP:0002345) | 2.95835184 |
| 48 | Abnormality of the parathyroid morphology (HP:0011766) | 2.94416966 |
| 49 | Hyperthyroidism (HP:0000836) | 2.91912046 |
| 50 | Abnormality of methionine metabolism (HP:0010901) | 2.89762533 |
| 51 | Abnormality of complement system (HP:0005339) | 2.88247786 |
| 52 | Abnormal eating behavior (HP:0100738) | 2.87658439 |
| 53 | Generalized tonic-clonic seizures (HP:0002069) | 2.87656122 |
| 54 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.87055455 |
| 55 | Depression (HP:0000716) | 2.85266890 |
| 56 | Hypercholesterolemia (HP:0003124) | 2.83049284 |
| 57 | Spastic diplegia (HP:0001264) | 2.81249349 |
| 58 | Anxiety (HP:0000739) | 2.77480217 |
| 59 | Intention tremor (HP:0002080) | 2.76790336 |
| 60 | Abnormality of serum amino acid levels (HP:0003112) | 2.75995217 |
| 61 | Neonatal onset (HP:0003623) | 2.75622313 |
| 62 | Hyperparathyroidism (HP:0000843) | 2.74587329 |
| 63 | Gout (HP:0001997) | 2.70387121 |
| 64 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.59371801 |
| 65 | Dicarboxylic aciduria (HP:0003215) | 2.59371801 |
| 66 | Cerebral hypomyelination (HP:0006808) | 2.58014067 |
| 67 | Hepatocellular carcinoma (HP:0001402) | 2.56949809 |
| 68 | Abnormality of the intrinsic pathway (HP:0010989) | 2.54303638 |
| 69 | Annular pancreas (HP:0001734) | 2.54297741 |
| 70 | Truncus arteriosus (HP:0001660) | 2.53021194 |
| 71 | Lethargy (HP:0001254) | 2.51459366 |
| 72 | Abnormal pancreas size (HP:0012094) | 2.50664696 |
| 73 | Epileptiform EEG discharges (HP:0011182) | 2.50285408 |
| 74 | Hyperbilirubinemia (HP:0002904) | 2.50251664 |
| 75 | Atonic seizures (HP:0010819) | 2.49535458 |
| 76 | Poor speech (HP:0002465) | 2.48058830 |
| 77 | Ankle clonus (HP:0011448) | 2.47913035 |
| 78 | Abnormality of nucleobase metabolism (HP:0010932) | 2.47669400 |
| 79 | Metabolic acidosis (HP:0001942) | 2.47146756 |
| 80 | Irritability (HP:0000737) | 2.47061812 |
| 81 | Neoplasm of the adrenal cortex (HP:0100641) | 2.45621753 |
| 82 | Skin nodule (HP:0200036) | 2.44744913 |
| 83 | Status epilepticus (HP:0002133) | 2.44560669 |
| 84 | Cholecystitis (HP:0001082) | 2.42237636 |
| 85 | Abnormal gallbladder physiology (HP:0012438) | 2.42237636 |
| 86 | Increased circulating renin level (HP:0000848) | 2.37610030 |
| 87 | Spastic gait (HP:0002064) | 2.36902008 |
| 88 | EEG with generalized epileptiform discharges (HP:0011198) | 2.32711436 |
| 89 | Increased hepatocellular lipid droplets (HP:0006565) | 2.32333648 |
| 90 | Polyphagia (HP:0002591) | 2.31425625 |
| 91 | Spontaneous abortion (HP:0005268) | 2.29258388 |
| 92 | Malnutrition (HP:0004395) | 2.29236566 |
| 93 | Turricephaly (HP:0000262) | 2.28084258 |
| 94 | Abnormality of purine metabolism (HP:0004352) | 2.27976372 |
| 95 | Renal Fanconi syndrome (HP:0001994) | 2.27646155 |
| 96 | Torticollis (HP:0000473) | 2.27603988 |
| 97 | Conjugated hyperbilirubinemia (HP:0002908) | 2.27145646 |
| 98 | Steatorrhea (HP:0002570) | 2.25713359 |
| 99 | Sensorimotor neuropathy (HP:0007141) | 2.24489377 |
| 100 | Back pain (HP:0003418) | 2.24318315 |
| 101 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.23652934 |
| 102 | Hemiparesis (HP:0001269) | 2.23121748 |
| 103 | Postural instability (HP:0002172) | 2.22318904 |
| 104 | Abnormality of binocular vision (HP:0011514) | 2.21660174 |
| 105 | Diplopia (HP:0000651) | 2.21660174 |
| 106 | Craniofacial dystonia (HP:0012179) | 2.21204959 |
| 107 | Genetic anticipation (HP:0003743) | 2.20924650 |
| 108 | Cholelithiasis (HP:0001081) | 2.20296583 |
| 109 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.19219052 |
| 110 | Abnormality of the Achilles tendon (HP:0005109) | 2.19152080 |
| 111 | Late onset (HP:0003584) | 2.18088137 |
| 112 | Ventricular fibrillation (HP:0001663) | 2.17027361 |
| 113 | Hypsarrhythmia (HP:0002521) | 2.15307766 |
| 114 | Hypoglycemic seizures (HP:0002173) | 2.13427326 |
| 115 | Broad-based gait (HP:0002136) | 2.12535212 |
| 116 | Increased intramyocellular lipid droplets (HP:0012240) | 2.12099964 |
| 117 | Dysmetria (HP:0001310) | 2.11637089 |
| 118 | Abnormal gallbladder morphology (HP:0012437) | 2.10615563 |
| 119 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.09979382 |
| 120 | Absence seizures (HP:0002121) | 2.09528527 |
| 121 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.09067835 |
| 122 | Dysdiadochokinesis (HP:0002075) | 2.08435617 |
| 123 | Acute necrotizing encephalopathy (HP:0006965) | 2.07294897 |
| 124 | Cortical dysplasia (HP:0002539) | 2.05305005 |
| 125 | Focal dystonia (HP:0004373) | 2.05002673 |
| 126 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.01992321 |
| 127 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.01992321 |
| 128 | Adrenal hypoplasia (HP:0000835) | 1.99912377 |
| 129 | Mitochondrial inheritance (HP:0001427) | 1.99378277 |
| 130 | Myokymia (HP:0002411) | 1.97482724 |
| 131 | Cerebral edema (HP:0002181) | 1.96928806 |
| 132 | Lipid accumulation in hepatocytes (HP:0006561) | 1.96877124 |
| 133 | Sleep apnea (HP:0010535) | 1.96723552 |
| 134 | Poor eye contact (HP:0000817) | 1.96348772 |
| 135 | Brushfield spots (HP:0001088) | 1.96181570 |
| 136 | Abnormal cartilage morphology (HP:0002763) | 1.95738351 |
| 137 | Muscular hypotonia of the trunk (HP:0008936) | 1.95346691 |
| 138 | Abnormal EKG (HP:0003115) | 1.95289341 |
| 139 | Vascular calcification (HP:0004934) | 1.95007973 |
| 140 | Cerebral inclusion bodies (HP:0100314) | 1.94969542 |
| 141 | Vomiting (HP:0002013) | 1.93074597 |
| 142 | Incomplete penetrance (HP:0003829) | 1.92276068 |
| 143 | Esotropia (HP:0000565) | 1.91951000 |
| 144 | Progressive macrocephaly (HP:0004481) | 1.89780739 |
| 145 | Psychosis (HP:0000709) | 1.87670647 |
| 146 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.87333061 |
| 147 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.87333061 |
| 148 | Rickets (HP:0002748) | 1.86853561 |
| 149 | Bradykinesia (HP:0002067) | 1.86647217 |
| 150 | Prolonged QT interval (HP:0001657) | 1.86039386 |
| 151 | Nuclear cataract (HP:0100018) | 1.85713150 |
| 152 | Gait imbalance (HP:0002141) | 1.85128836 |
| 153 | Neurofibrillary tangles (HP:0002185) | 1.84455931 |
| 154 | Spastic tetraparesis (HP:0001285) | 1.81036178 |
| 155 | Hyperglycemia (HP:0003074) | 1.80762308 |
| 156 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.80155128 |
| 157 | Dialeptic seizures (HP:0011146) | 1.79981188 |
| 158 | Myoglobinuria (HP:0002913) | 1.79923818 |
| 159 | Upper motor neuron abnormality (HP:0002127) | 1.79415026 |
| 160 | Tetraplegia (HP:0002445) | 1.78060258 |
| 161 | Akinesia (HP:0002304) | 1.77976972 |
| 162 | Hyperuricemia (HP:0002149) | 1.76369401 |
| 163 | Increased purine levels (HP:0004368) | 1.76369401 |
| 164 | Amyloidosis (HP:0011034) | 1.75570641 |
| 165 | Hypercalcemia (HP:0003072) | 1.74954939 |
| 166 | Generalized aminoaciduria (HP:0002909) | 1.74891745 |
| 167 | Poor suck (HP:0002033) | 1.74729300 |
| 168 | Acute encephalopathy (HP:0006846) | 1.74402607 |
| 169 | Choreoathetosis (HP:0001266) | 1.73695935 |
| 170 | Atrioventricular block (HP:0001678) | 1.73571158 |
| 171 | Abnormality of the corticospinal tract (HP:0002492) | 1.73540971 |
| 172 | Hyperventilation (HP:0002883) | 1.73402228 |
| 173 | Myocardial infarction (HP:0001658) | 1.73285978 |
| 174 | Impaired smooth pursuit (HP:0007772) | 1.72841149 |
| 175 | Hypophosphatemic rickets (HP:0004912) | 1.72668626 |
| 176 | Death in childhood (HP:0003819) | 1.72132484 |
| 177 | Metaphyseal dysplasia (HP:0100255) | 1.71207645 |
| 178 | Abnormality of proline metabolism (HP:0010907) | 1.71114232 |
| 179 | Hydroxyprolinuria (HP:0003080) | 1.71114232 |
| 180 | Growth hormone excess (HP:0000845) | 1.69979078 |
| 181 | Abnormality of the gallbladder (HP:0005264) | 1.69697617 |
| 182 | Decreased circulating renin level (HP:0003351) | 1.69377080 |
| 183 | Unilateral renal agenesis (HP:0000122) | 1.69258115 |
| 184 | Esophageal varix (HP:0002040) | 1.68838667 |
| 185 | Pseudobulbar signs (HP:0002200) | 1.67038515 |
| 186 | Reticulocytosis (HP:0001923) | 1.66233805 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BRSK2 | 5.29089054 |
| 2 | BCKDK | 4.66583052 |
| 3 | MARK1 | 4.55654544 |
| 4 | BRSK1 | 3.95811313 |
| 5 | WEE1 | 3.55724228 |
| 6 | SIK1 | 3.11289281 |
| 7 | CASK | 3.04118643 |
| 8 | LATS2 | 2.64981455 |
| 9 | MAP3K9 | 2.62458595 |
| 10 | TRIB3 | 2.53704497 |
| 11 | STK16 | 2.49563712 |
| 12 | PKN2 | 2.46149018 |
| 13 | MAP2K4 | 2.43048886 |
| 14 | UHMK1 | 2.33722719 |
| 15 | NEK1 | 2.33275566 |
| 16 | ERN1 | 2.27415804 |
| 17 | SMG1 | 2.22171727 |
| 18 | PHKG2 | 2.20424951 |
| 19 | PHKG1 | 2.20424951 |
| 20 | DAPK2 | 2.06183059 |
| 21 | MINK1 | 2.00548594 |
| 22 | FGFR4 | 1.93704552 |
| 23 | VRK2 | 1.83269028 |
| 24 | MAP3K12 | 1.81328552 |
| 25 | MAP3K4 | 1.81239285 |
| 26 | TAF1 | 1.80118893 |
| 27 | ICK | 1.72412290 |
| 28 | ERBB4 | 1.69852135 |
| 29 | ARAF | 1.59334302 |
| 30 | GRK5 | 1.58459368 |
| 31 | MAP3K11 | 1.56403817 |
| 32 | KSR2 | 1.50262087 |
| 33 | PAK3 | 1.47103286 |
| 34 | PAK6 | 1.43865936 |
| 35 | PDK3 | 1.40228053 |
| 36 | PDK4 | 1.40228053 |
| 37 | NTRK2 | 1.34594025 |
| 38 | PNCK | 1.33890993 |
| 39 | DYRK2 | 1.27042180 |
| 40 | SIK2 | 1.22607561 |
| 41 | CAMKK2 | 1.20699038 |
| 42 | PBK | 1.17763740 |
| 43 | RIPK1 | 1.16148435 |
| 44 | LATS1 | 1.14955216 |
| 45 | PINK1 | 1.14308761 |
| 46 | TAOK1 | 1.13704006 |
| 47 | STK38 | 1.13433202 |
| 48 | PRKCZ | 1.13058070 |
| 49 | KSR1 | 1.11051602 |
| 50 | TYRO3 | 1.08744833 |
| 51 | PRKCG | 1.07639742 |
| 52 | SGK494 | 1.05758556 |
| 53 | SGK223 | 1.05758556 |
| 54 | PLK2 | 1.03451247 |
| 55 | NTRK1 | 1.03326480 |
| 56 | BRAF | 1.02228627 |
| 57 | CAMK2B | 1.02190444 |
| 58 | ALK | 1.01543337 |
| 59 | CSNK1G2 | 0.96709329 |
| 60 | MST1R | 0.95440854 |
| 61 | WNK4 | 0.92753908 |
| 62 | MAP3K2 | 0.92711500 |
| 63 | CAMKK1 | 0.89355910 |
| 64 | EPHA2 | 0.88657839 |
| 65 | ABL2 | 0.87650997 |
| 66 | PRKCH | 0.85936951 |
| 67 | RET | 0.83992119 |
| 68 | PTK6 | 0.83759554 |
| 69 | CAMK1 | 0.80842631 |
| 70 | PRKAA1 | 0.79563511 |
| 71 | AURKA | 0.78940026 |
| 72 | CAMK2G | 0.78869481 |
| 73 | CSNK1G3 | 0.77315043 |
| 74 | MAPK12 | 0.77083384 |
| 75 | MAP3K10 | 0.75847959 |
| 76 | MAP2K6 | 0.75704135 |
| 77 | CDK15 | 0.75648247 |
| 78 | FGFR2 | 0.73994280 |
| 79 | CDK11A | 0.73944502 |
| 80 | CDK6 | 0.73865546 |
| 81 | ERBB2 | 0.73825026 |
| 82 | STK38L | 0.73118573 |
| 83 | CDK18 | 0.72310850 |
| 84 | ERBB3 | 0.71114852 |
| 85 | NTRK3 | 0.70654431 |
| 86 | LMTK2 | 0.69482916 |
| 87 | DYRK1A | 0.67848819 |
| 88 | CAMK2D | 0.66955438 |
| 89 | MTOR | 0.66901631 |
| 90 | DAPK1 | 0.66532245 |
| 91 | MAP2K1 | 0.65966644 |
| 92 | CSNK1A1L | 0.65757940 |
| 93 | EPHA4 | 0.64930258 |
| 94 | MAPKAPK5 | 0.64424470 |
| 95 | HIPK2 | 0.63767082 |
| 96 | PDK2 | 0.63530955 |
| 97 | STK11 | 0.62950486 |
| 98 | PDPK1 | 0.61747685 |
| 99 | CSNK1G1 | 0.61486530 |
| 100 | TESK1 | 0.60977775 |
| 101 | CAMK2A | 0.60253071 |
| 102 | CDK5 | 0.59820068 |
| 103 | MAPK15 | 0.59739928 |
| 104 | PRKACG | 0.58955987 |
| 105 | PTK2 | 0.57863512 |
| 106 | PRKCI | 0.57402691 |
| 107 | TNIK | 0.57398613 |
| 108 | SCYL2 | 0.57098023 |
| 109 | MAP3K7 | 0.56629858 |
| 110 | CSNK1E | 0.55926295 |
| 111 | GSK3A | 0.55094898 |
| 112 | MAP2K7 | 0.54907165 |
| 113 | PRKD3 | 0.54202983 |
| 114 | MAPK11 | 0.53580708 |
| 115 | GRK6 | 0.53452954 |
| 116 | LIMK1 | 0.52075204 |
| 117 | WNK3 | 0.51343946 |
| 118 | AKT2 | 0.50605393 |
| 119 | SGK2 | 0.50251686 |
| 120 | DYRK1B | 0.47824083 |
| 121 | JAK2 | 0.46297114 |
| 122 | STK39 | 0.45491180 |
| 123 | EPHB2 | 0.45197512 |
| 124 | CAMK1G | 0.44727392 |
| 125 | SGK1 | 0.44561438 |
| 126 | MAP3K6 | 0.43967302 |
| 127 | CAMK4 | 0.42997339 |
| 128 | RPS6KA2 | 0.42655254 |
| 129 | FER | 0.42528767 |
| 130 | MAPK4 | 0.42256399 |
| 131 | DAPK3 | 0.42133766 |
| 132 | WNK1 | 0.41680584 |
| 133 | SGK3 | 0.41599272 |
| 134 | INSRR | 0.41325942 |
| 135 | IRAK2 | 0.40583111 |
| 136 | MAPK13 | 0.39757205 |
| 137 | RPS6KA3 | 0.38862392 |
| 138 | AKT3 | 0.38343609 |
| 139 | BMX | 0.37845637 |
| 140 | PDGFRA | 0.37774087 |
| 141 | MARK2 | 0.36864281 |
| 142 | PDK1 | 0.35637415 |
| 143 | CDK14 | 0.35547644 |
| 144 | BRD4 | 0.32824766 |
| 145 | PKN1 | 0.31830080 |
| 146 | NME1 | 0.30886898 |
| 147 | MAP3K1 | 0.30818632 |
| 148 | MAP2K2 | 0.29222095 |
| 149 | MAPK10 | 0.27369063 |
| 150 | RPS6KA1 | 0.27185008 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.90340330 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.60871234 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.48553887 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.11869733 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.97397868 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.96280062 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.67723603 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.67675908 |
| 9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.62211776 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.46069165 |
| 11 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.36982272 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.36765022 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.22218387 |
| 14 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.19858198 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.18226141 |
| 16 | Circadian entrainment_Homo sapiens_hsa04713 | 2.09689616 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.05425892 |
| 18 | Morphine addiction_Homo sapiens_hsa05032 | 2.04975525 |
| 19 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.02584679 |
| 20 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.00578868 |
| 21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.00404344 |
| 22 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.98701402 |
| 23 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.98655415 |
| 24 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.97851162 |
| 25 | Cocaine addiction_Homo sapiens_hsa05030 | 1.96493079 |
| 26 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.94874744 |
| 27 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.92876729 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.83500839 |
| 29 | Long-term potentiation_Homo sapiens_hsa04720 | 1.82033127 |
| 30 | Bile secretion_Homo sapiens_hsa04976 | 1.81083549 |
| 31 | Peroxisome_Homo sapiens_hsa04146 | 1.75982257 |
| 32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.74020119 |
| 33 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.68515677 |
| 34 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.67033516 |
| 35 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.63879707 |
| 36 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.60007185 |
| 37 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.57371235 |
| 38 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.56468091 |
| 39 | Parkinsons disease_Homo sapiens_hsa05012 | 1.53285588 |
| 40 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.51972965 |
| 41 | Alzheimers disease_Homo sapiens_hsa05010 | 1.51406914 |
| 42 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.51261865 |
| 43 | Histidine metabolism_Homo sapiens_hsa00340 | 1.48954251 |
| 44 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.48735199 |
| 45 | Carbon metabolism_Homo sapiens_hsa01200 | 1.47294843 |
| 46 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.45379754 |
| 47 | Phototransduction_Homo sapiens_hsa04744 | 1.43011329 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.41484242 |
| 49 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.39355836 |
| 50 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.35374357 |
| 51 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.33949715 |
| 52 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.33049335 |
| 53 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.32795981 |
| 54 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.32640325 |
| 55 | Retinol metabolism_Homo sapiens_hsa00830 | 1.29656616 |
| 56 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.28544437 |
| 57 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.25318701 |
| 58 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.23048581 |
| 59 | Renin secretion_Homo sapiens_hsa04924 | 1.22239018 |
| 60 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.17847065 |
| 61 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.17211242 |
| 62 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.16233211 |
| 63 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.12803257 |
| 64 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.12423131 |
| 65 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.10300322 |
| 66 | Axon guidance_Homo sapiens_hsa04360 | 1.08536394 |
| 67 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.06962671 |
| 68 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.06168844 |
| 69 | Long-term depression_Homo sapiens_hsa04730 | 1.06030487 |
| 70 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.05848541 |
| 71 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.05613537 |
| 72 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.04077867 |
| 73 | Sulfur relay system_Homo sapiens_hsa04122 | 1.03608981 |
| 74 | Huntingtons disease_Homo sapiens_hsa05016 | 1.01177278 |
| 75 | Melanogenesis_Homo sapiens_hsa04916 | 0.99664997 |
| 76 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.98953478 |
| 77 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.98135483 |
| 78 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.97567783 |
| 79 | Taste transduction_Homo sapiens_hsa04742 | 0.97319686 |
| 80 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.93181275 |
| 81 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.89298732 |
| 82 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.88222206 |
| 83 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.88086571 |
| 84 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.87297020 |
| 85 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.86563435 |
| 86 | ABC transporters_Homo sapiens_hsa02010 | 0.84446756 |
| 87 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.83597379 |
| 88 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.82870472 |
| 89 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.81001962 |
| 90 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.80880934 |
| 91 | Gap junction_Homo sapiens_hsa04540 | 0.80074260 |
| 92 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.77797090 |
| 93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.74882554 |
| 94 | Lysine degradation_Homo sapiens_hsa00310 | 0.74127995 |
| 95 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.73136427 |
| 96 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.70278068 |
| 97 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.69398633 |
| 98 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.66242628 |
| 99 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65529729 |
| 100 | Olfactory transduction_Homo sapiens_hsa04740 | 0.65219572 |
| 101 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.64707071 |
| 102 | Glioma_Homo sapiens_hsa05214 | 0.64037168 |
| 103 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.56396285 |
| 104 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.56336685 |
| 105 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.56262886 |
| 106 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.55443902 |
| 107 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.52240763 |
| 108 | Prion diseases_Homo sapiens_hsa05020 | 0.52152013 |
| 109 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.51482615 |
| 110 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.50404774 |
| 111 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.49540963 |
| 112 | Alcoholism_Homo sapiens_hsa05034 | 0.49278472 |
| 113 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.47008123 |
| 114 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.46381265 |
| 115 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.45671883 |
| 116 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.45479696 |
| 117 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.45474140 |
| 118 | Circadian rhythm_Homo sapiens_hsa04710 | 0.45368688 |
| 119 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.44344043 |
| 120 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.43531674 |
| 121 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.43447046 |
| 122 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.43153242 |
| 123 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.40782982 |
| 124 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.40380379 |
| 125 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.39690720 |
| 126 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.38466875 |
| 127 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.37085486 |
| 128 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.36875285 |
| 129 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.36849818 |
| 130 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.35698139 |
| 131 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.35040123 |
| 132 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.34462222 |
| 133 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.34057175 |
| 134 | Insulin resistance_Homo sapiens_hsa04931 | 0.33509777 |
| 135 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.32429664 |
| 136 | Metabolic pathways_Homo sapiens_hsa01100 | 0.32070901 |
| 137 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.28794474 |
| 138 | Ribosome_Homo sapiens_hsa03010 | 0.28702021 |
| 139 | GABAergic synapse_Homo sapiens_hsa04727 | 0.28566767 |
| 140 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.26865570 |
| 141 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26180620 |
| 142 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.24528904 |
| 143 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24368457 |
| 144 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.23819763 |
| 145 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.22354430 |
| 146 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.20795197 |
| 147 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.18810798 |
| 148 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.18283834 |
| 149 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.16572414 |
| 150 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.16215955 |
| 151 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.14933136 |
| 152 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.05593080 |
| 153 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.02572257 |
| 154 | Insulin secretion_Homo sapiens_hsa04911 | 0.02035594 |
| 155 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.00963423 |
| 156 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.00653603 |
| 157 | Nicotine addiction_Homo sapiens_hsa05033 | 0.00580593 |
| 158 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.00030254 |
| 159 | Salivary secretion_Homo sapiens_hsa04970 | -0.0502584 |
| 160 | Bladder cancer_Homo sapiens_hsa05219 | -0.0390573 |
| 161 | mTOR signaling pathway_Homo sapiens_hsa04150 | -0.0346385 |
| 162 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | -0.0218817 |
| 163 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0184661 |

